Sinovac Vaccine Shows 78% Efficacy in Brazilian Trial, Details Sparse Sinovac Vaccine Shows 78% Efficacy in Brazilian Trial, Details Sparse
A COVID-19 vaccine developed by China ' s Sinovac Biotech was 78% effective in a late-stage Brazilian trial and entirely prevented severe cases, a source said on Thursday, boosting Chinese efforts to catch up with Western vaccine makers.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
More News: Biotechnology | Brazil Health | China Health | COVID-19 | Health | Infectious Diseases | Vaccines